Literature DB >> 10839307

Effects of soy foods on ovarian function in premenopausal women.

A H Wu1, F Z Stanczyk, S Hendrich, P A Murphy, C Zhang, P Wan, M C Pike.   

Abstract

It has been proposed that the high intake of soy foods among Asians may partly explain their lower rates of breast cancer, perhaps by lowering endogenous oestrogen levels, although this has been inadequately studied. Twenty healthy cycling premenopausal women (ten Asians and ten non-Asians) participated in a 7-month soy intervention study which was designed to investigate the effect of supplementation on ovarian function. Asian soy foods (tofu, soymilk, green soybean peas) in the amount of approximately 32 mg of isoflavones per day were added to the women's diets for three menstrual cycles. The women's baseline (two cycles) serum hormone levels were compared to levels during soy intervention (three cycles) and levels after intervention (two cycles). During the entire study period, subjects provided almost daily overnight urine samples and blood specimens during specified days of their menstrual cycles. The day of urinary luteinizing hormone (LH) peak was used as a marker for the day of ovulation. Knowledge of day of ovulation allowed comparison of hormone measurements at baseline to those obtained during intervention and recovery cycles with standardization of day of cycle. Soy intervention was associated with a statistically significant reduction in serum luteal oestradiol level (-9.3%, P < 0.05), but there were no significant changes in follicular phase oestradiol, follicular or luteal phase progesterone, sex hormone-binding globulin or menstrual cycle length. This significant reduction in luteal phase oestradiol was, however, observed only among Asian (-17.4%) but not among non-Asian (-1.2%) participants; urinary excretion of isoflavones was higher among Asians than non-Asians (29.2 vs 17.1 micromol day(-1), P= 0.16) during the intervention period. Thus, supplementation using traditional soy foods reduced serum oestradiol levels among Asian participants in this study. Differences in the type of soy products (i.e. traditional soy foods versus soy protein products), amount of isoflavones, and race/ethnicity of participants may have contributed to the divergent results. Larger soy intervention studies designed specifically to include participants of different race/ethnicities and using both traditional soy foods and soy protein products providing comparable doses of isoflavones are needed to definitively determine the effect of soy on ovarian function.

Entities:  

Mesh:

Year:  2000        PMID: 10839307      PMCID: PMC2363237          DOI: 10.1054/bjoc.1999.1218

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  The role of soy products in reducing risk of cancer.

Authors:  M Messina; S Barnes
Journal:  J Natl Cancer Inst       Date:  1991-04-17       Impact factor: 13.506

2.  Single luteal phase serum progesterone assay as an indicator of ovulation.

Authors:  R Israel; D R Mishell; S C Stone; I H Thorneycroft; D L Moyer
Journal:  Am J Obstet Gynecol       Date:  1972-04-15       Impact factor: 8.661

3.  A randomized comparison of nonoral estradiol delivery in postmenopausal women.

Authors:  F Z Stanczyk; D Shoupe; V Nunez; P Macias-Gonzales; M A Vijod; R A Lobo
Journal:  Am J Obstet Gynecol       Date:  1988-12       Impact factor: 8.661

4.  A double-antibody radioimmunoassay for serum progesterone using progesterone-3-(O-carboxymethyl) oximino-[125I]-iodo-histamine as radioligand.

Authors:  J Z Scott; F Z Stanczyk; U Goebelsmann; D R Mishell
Journal:  Steroids       Date:  1978-03       Impact factor: 2.668

5.  Dietary intake and sources of isoflavones among Japanese.

Authors:  K Wakai; I Egami; K Kato; T Kawamura; A Tamakoshi; Y Lin; T Nakayama; M Wada; Y Ohno
Journal:  Nutr Cancer       Date:  1999       Impact factor: 2.900

6.  Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii.

Authors:  A A Franke; J H Hankin; M C Yu; G Maskarinec; S H Low; L J Custer
Journal:  J Agric Food Chem       Date:  1999-03       Impact factor: 5.279

Review 7.  Western diet and Western diseases: some hormonal and biochemical mechanisms and associations.

Authors:  H Adlercreutz
Journal:  Scand J Clin Lab Invest Suppl       Date:  1990

8.  Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women.

Authors:  X Xu; H J Wang; P A Murphy; L Cook; S Hendrich
Journal:  J Nutr       Date:  1994-06       Impact factor: 4.798

9.  Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet.

Authors:  H Adlercreutz; H Honjo; A Higashi; T Fotsis; E Hämäläinen; T Hasegawa; H Okada
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

Review 10.  Diet and breast cancer.

Authors:  H Adlercreutz; Y Mousavi; K Höckerstedt
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

View more
  20 in total

Review 1.  Adult ovarian function can be affected by high levels of soy.

Authors:  Wendy N Jefferson
Journal:  J Nutr       Date:  2010-10-27       Impact factor: 4.798

2.  Usual dietary isoflavone intake and reproductive function across the menstrual cycle.

Authors:  Amanda C Filiberto; Sunni L Mumford; Anna Z Pollack; Cuilin Zhang; Edwina H Yeung; Karen C Schliep; Neil J Perkins; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2013-08-31       Impact factor: 7.329

3.  Urinary sex steroid excretion levels during a soy intervention among young girls: a pilot study.

Authors:  Gertraud Maskarinec; Yukiko Morimoto; Rachel Novotny; Frank J Nordt; Frank Z Stanczyk; Adrian A Franke
Journal:  Nutr Cancer       Date:  2005       Impact factor: 2.900

Review 4.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula.

Authors:  Karl K Rozman; Jatinder Bhatia; Antonia M Calafat; Christina Chambers; Martine Culty; Ruth A Etzel; Jodi A Flaws; Deborah K Hansen; Patricia B Hoyer; Elizabeth H Jeffery; James S Kesner; Sue Marty; John A Thomas; David Umbach
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-08

5.  Dietary iron intake and risk of endometrial cancer: a population-based case-control study in Shanghai, China.

Authors:  Asha R Kallianpur; Sang-Ah Lee; Wang-Hong Xu; Wei Zheng; Yu-Tang Gao; Hui Cai; Zhi-Xian Ruan; Yong-Bing Xiang; Xiao Ou Shu
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 6.  The pros and cons of phytoestrogens.

Authors:  Heather B Patisaul; Wendy Jefferson
Journal:  Front Neuroendocrinol       Date:  2010-03-27       Impact factor: 8.606

7.  Endogenous and exogenous equol are antiestrogenic in reproductive tissues of apolipoprotein e-null mice.

Authors:  Fitriya N Dewi; Charles E Wood; Johanna W Lampe; Meredith A J Hullar; Adrian A Franke; Deborah L Golden; Michael R Adams; J Mark Cline
Journal:  J Nutr       Date:  2012-08-29       Impact factor: 4.798

8.  The specific role of isoflavones on estrogen metabolism in premenopausal women.

Authors:  Nagi B Kumar; Alan Cantor; Kathy Allen; Diane Riccardi; Charles E Cox
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

9.  Soy intake is associated with increased 2-hydroxylation and decreased 16alpha-hydroxylation of estrogens in Asian-American women.

Authors:  Barbara J Fuhrman; Ruth Pfeiffer; Xia Xu; Anna H Wu; Larissa Korde; Mitchell H Gail; Larry K Keefer; Timothy D Veenstra; Robert N Hoover; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

10.  Marked individual variation in isoflavone metabolism after a soy challenge can modulate the skeletal effect of isoflavones in premenopausal women.

Authors:  Ho Seok Kwak; So Young Park; Mi Gyeong Kim; Chang Hoon Yim; Hyun Koo Yoon; Ki Ok Han
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.